Recombinant Trypsin is a genetically engineered protein expressed in E-Coli. As such it is totally animal free, free from contaminating enzymes like chymotrysin as well as protease inhibitors. It is highly stable with a high purity. It is widely used in insulin manufacturing, Vaccines Manufacturing and cell culture applications.
The global market for Recombinant Trypsin is estimated to increase from US$ 29 million in 2021 to reach US$ 52 million by 2028, exhibiting a CAGR of 8.5% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
In China, key players of Recombinant Trypsin include Novozymes, Yaxin Bio, Thermo Fisher, etc. The top three players hold a share about 58%. Europe is the largest producer of Recombinant Trypsin in China market, holds a share over 44%, followed by United States and China. The largest China market is North China, holds a share about 31%, followed by East China and South China, with around 20% and 10% market share respectively.
Report Coverage
This latest report provides a deep insight into the global Recombinant Trypsin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Recombinant Trypsin market, with both quantitative and qualitative data, to help readers understand how the Recombinant Trypsin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Recombinant Trypsin market and forecasts the market size by Type (Solid and Liquid,), by Application (Insulin Manufacturing, Cell Culture and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Solid
Liquid
Segmentation by application
Insulin Manufacturing
Cell Culture
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novozymes
Thermo Fisher
Merck
Sartorius
Yaxin Bio
Yocon Hengye Bio
BasalMedia
Pu Tai Bio
Chapter Introduction
Chapter 1: Scope of Recombinant Trypsin, Research Methodology, etc.
Chapter 2: Executive Summary, global Recombinant Trypsin market size (sales and revenue) and CAGR, Recombinant Trypsin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Recombinant Trypsin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Recombinant Trypsin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Recombinant Trypsin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Novozymes, Thermo Fisher, Merck, Sartorius, Yaxin Bio, Yocon Hengye Bio, BasalMedia and Pu Tai Bio, etc.
Chapter 14: Research Findings and Conclusion